Showing results (101-110 of 119) with videos related to
Sort By:
Pageof 12
Genes|September 28, 2023
The Prediction Analysis of Microarray 50 (PAM50) Gene Expression Classifier Utilized in Indeterminate-Risk Breast Cancer Patients in Hungary: A Consecutive 5-Year ExperienceMagdolna Dank, Dorottya Mühl, Annamária Pölhös, et al.Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|May 24, 2016
PREDICTIVE VALUE OF SOMATIC MUTATIONS FOR THE DEVELOPMENT OF MALIGNANCY IN THYROID NODULES BY CYTOPATHOLOGYCsaba Halászlaki, Bálint Tóbiás, Bernadett Balla, et al.Medicina (Kaunas, Lithuania)|January 21, 2023
Impact of a Targeted Project for Shortening of Imaging Diagnostic Waiting Time in Patients with Suspected Oncological Diseases in HungaryZsombor Mátyás Papp, László Szakács, Shayan-Salehi Hajivandi, et al.European Journal of Hospital Pharmacy : Science and Practice|July 8, 2025
How to manage the overwhelming amount of database-detected interactions? A focus group meeting study on the management of database-detected risks of drug interactionsDénes Kleiner, Faraz Haghverdi, Orsolya Szépe, et al.Blood|February 11, 2020
Platelet glycoprotein VI promotes metastasis through interaction with cancer cell-derived galectin-3Elmina Mammadova-Bach, Jesus Gil-Pulido, Edita Sarukhanyan, et al.Pathology Oncology Research : POR|August 12, 2015
Genetic Alterations in Hungarian Patients with Papillary Thyroid CancerBálint Tobiás, Csaba Halászlaki, Bernadett Balla, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 22, 2015
CEREBEL (EGF111438): A Phase III, Randomized, Open-Label Study of Lapatinib Plus Capecitabine Versus Trastuzumab Plus Capecitabine in Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast CancerXavier Pivot, Alexey Manikhas, Bogdan Żurawski, et al.Wiener Klinische Wochenschrift|June 16, 2010
Current standards in the treatment of metastatic breast cancer with focus on Lapatinib: a review by a Central European Consensus PanelGuenther G Steger, Jitka Abrahámová, Florin Bacanu, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 31, 2003
Phase III study of letrozole versus tamoxifen as first-line therapy of advanced breast cancer in postmenopausal women: analysis of survival and update of efficacy from the International Letrozole Breast Cancer GroupHenning Mouridsen, Mikhail Gershanovich, Yan Sun, et al.Journal of Cancer Policy|December 24, 2025
Social framework to judge the importance of breast cancerZsuzsa Réka Pozsár, Krisztina Tóth, Marianna Moizs, et al.Pageof 12